About of onco-nephrology: Chronic kidney disease in oncology patients not hospitalized [0.03%]
论肿瘤肾病学：肿瘤非住院患者的慢性肾脏疾病
Manuel Heras Benito,Leonardo Calle García,María José Fernández-Reyes Luis
Manuel Heras Benito
How to design, apply and assess a Mentoring programme in chronic kidney disease: Narrative impact assessment in six health care centres [0.03%]
慢性肾脏病照护中辅导项目的策划、推行及评估：六个医疗中心的故事性影响评估
Helena García-Llana,Raquel Serrano,Gemma Oliveras et al.
Helena García-Llana et al.
Background and objective: Chronic kidney disease (CKD) requires patients to participate in an adaptation process, which may be facilitated with the support of healthcare professionals and trained peers. The objective of t...
Multicenter Study
Nefrologia. 2019 Nov-Dec;39(6):603-611. DOI:10.1016/j.nefro.2019.04.002 2019
Genitourinary schistosomiasis in a 20-year-old patient from Madagascar with persistent hematuria, associated with parasitosis from Trichuris trichuria and Necator americanus [0.03%]
一名来自马达加斯加的20岁患者，患有血尿持续存在并伴有毛首线虫和美洲钩虫寄生的泌尿生殖系统血吸虫病
Anabertha Narváez,Nisrine Arhda,Marta Pais et al.
Anabertha Narváez et al.
Case Reports
Nefrologia. 2019 Sep-Oct;39(5):559-560. DOI:10.1016/j.nefro.2019.02.007 2019
Jessy Korina Peña Esparragoza,María Pérez Fernández,Patricia Martínez Miguel et al.
Jessy Korina Peña Esparragoza et al.
Case Reports
Nefrologia. 2020 Mar-Apr;40(2):209-210. DOI:10.1016/j.nefro.2019.03.015 2020
Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease [0.03%]
直接抗病毒药物治疗HCV患者中度至重度慢性肾病的有效性和安全性分析
Ezequiel Ridruejo,Rebeca Garcia-Agudo,Manuel Mendizabal et al.
Ezequiel Ridruejo et al.
Background and aims: The advent of direct-acting antiviral agents promises to change the management of hepatitis C virus infection (HCV) in patients with chronic kidney disease (CKD), a patient group in which the treatmen...
Observational Study
Nefrologia. 2020 Jan-Feb;40(1):46-52. DOI:10.1016/j.nefro.2019.03.013 2020
ABO-incompatible living-donor kidney transplantation: Study of 48 patients after desensitisation [0.03%]
不兼容供体肾移植免疫耐受的临床研究
Constantino Fernández Rivera,María Calvo Rodríguez,Andrés López Muñíz et al.
Constantino Fernández Rivera et al.
Background: ABO-incompatible living-donor kidney transplantation was regarded as an absolute contraindication. However, it has been carried out for years with good outcomes. ...
Taurolidine as adjuvant treatment of relapsing peritonitis in peritoneal dialysis patients [0.03%]
腹膜透析再发性腹膜炎的辅助治疗——taurolidine的作用
Kamila Klimek,Nuria Aresté Fosalba,Miguel Ángel Ramírez López et al.
Kamila Klimek et al.
Relapsing peritonitis in peritoneal dialysis patients is one of the complications that jeopardizes the continuity of the technique. It is often associated with the formation of biofilm in the lumen of the catheter. To date, its removal rema...
Case Reports
Nefrologia. 2020 Mar-Apr;40(2):197-201. DOI:10.1016/j.nefro.2019.03.014 2020
Metformin and diuretics [0.03%]
二甲双胍与利尿剂
Yaiza Rivero Viera,Ingrid Auyanet Saavedra,Rita Guerra Rodríguez et al.
Yaiza Rivero Viera et al.
A familial Mediterranean fever patient with double homozygous mutations treated with anakinra after kidney transplantation [0.03%]
一种地中海热患者在肾脏移植后使用安纳金刚接受治疗
Nuri Baris Hasbal,Yener Koc,Mustafa Sevinc et al.
Nuri Baris Hasbal et al.
Case Reports
Nefrologia. 2020 Sep-Oct;40(5):563-564. DOI:10.1016/j.nefro.2019.03.012 2020
Leticia Cuarental,David Sucunza-Sáenz,Lara Valiño-Rivas et al.
Leticia Cuarental et al.
Mitogen-activated protein kinases (MAP kinases) are functionally connected kinases that regulate key cellular process involved in kidney disease such as all survival, death, differentiation and proliferation. The typical MAP kinase module i...